Anticoagulants Top Meeting Agenda
ESC 2011 — PARIS — The ARISTOTLE trial pitting the novel anticoagulant apixaban against warfarin for preventing stroke in patients with atrial fibrillation looks like it will be the stand-out of this year's meeting of the European Society of Cardiology. This exclusive interview previews the meeting.
Keywords: ESC Congress
< Back to Listings